Clinical Trial Update: Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update notes that intravesical instillation of TARA-002 for high-grade non-muscle invasive bladder cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-muscle Invasive Bladder Cancer

Drugs mentioned

• TARA-002

Snippet

Sponsor: Protara Therapeutics | Conditions: Non-muscle Invasive Bladder Cancer | Phase 2 | Status: RECRUITING